Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity 86Y- or 177Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates

MLA

Jorge A. Carrasquillo, et al. “Theranostic Pretargeted Radioimmunotherapy of Colorectal Cancer Xenografts in Mice Using Picomolar Affinity 86Y- or 177Lu-DOTA-Bn Binding ScFv C825/GPA33 IgG Bispecific Immunoconjugates.” European Journal of Nuclear Medicine and Molecular Imaging, vol. 43, Nov. 2015, pp. 925–37. EBSCOhost, https://doi.org/10.1007/s00259-015-3254-8.

APA

Jorge A. Carrasquillo, Joseph A. O’Donoghue, Sandhya Chalasani, Pat Zanzonico, K. Dane Wittrup, Achim A. Jungbluth, Peter Smith-Jones, Hong Xu, Blesida Punzalan, Sang-gyu Lee, Edward K. Fung, Hong-fen Guo, Nai-Kong V. Cheung, Steven M. Larson, & Sarah M. Cheal. (2015). Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity 86Y- or 177Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates. European Journal of Nuclear Medicine and Molecular Imaging, 43, 925–937. https://doi.org/10.1007/s00259-015-3254-8

Chicago

Jorge A. Carrasquillo, Joseph A. O’Donoghue, Sandhya Chalasani, Pat Zanzonico, K. Dane Wittrup, Achim A. Jungbluth, Peter Smith-Jones, et al. 2015. “Theranostic Pretargeted Radioimmunotherapy of Colorectal Cancer Xenografts in Mice Using Picomolar Affinity 86Y- or 177Lu-DOTA-Bn Binding ScFv C825/GPA33 IgG Bispecific Immunoconjugates.” European Journal of Nuclear Medicine and Molecular Imaging 43 (November): 925–37. doi:10.1007/s00259-015-3254-8.